PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC
BSE2592.707.65 (+0.3 %)
PREV CLOSE ( ) 2585.05
OPEN PRICE ( ) 2580.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1120
TODAY'S LOW / HIGH ( )2568.00 2610.00
52 WK LOW / HIGH ( )1701 2670
NSE2596.3512.8 (+0.5 %)
PREV CLOSE( ) 2583.55
OPEN PRICE ( ) 2585.00
BID PRICE (QTY) 2596.35 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 23845
TODAY'S LOW / HIGH( ) 2580.05 2608.90
52 WK LOW / HIGH ( )1681 2675
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 21-11 1950
Management Info
R A Shah - Chairman S Sridhar - Managing Director
Registered Office

Address The Capital, 1802/1901,Plot No.c-70, G Block,Bandra Kurla Complex, Bandra (East),
Mumbai,
Maharashtra-400051

Phone 91 22 6693 2000

Email contactus.india@pfizer.com

Website www.pfizerindia.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
20Jun Pfizer informs about analyst meet
Pursuant to Regulation 30 of the Listing Regulations, Pfizer has informe..
08May Pfizer reports 54% rise in Q4 net profit
Pfizer has reported results for the fourth quarter and year ended March..
08May Pfizer falls despite reporting 54% ris
Pfizer is currently trading at Rs. 2426.00, down by 75.40 points or 3.01..
07May Board recommends Dividend
Pfizer Ltd has informed BSE that the Board of Directors of the Company a..
26Apr Board to consider FY18 results & Divi
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit1045.13600.7
Gross Profit 1525.4 5479.1
Operating Profit 1698.16145.8
Net Sales 5199.519801.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7430.85 (1.82%)
M.Cap (Rs. in Cr)15790.04
Astrazeneca Pharma I (BSE)
 1478.55 (9.32%)
M.Cap (Rs. in Cr)3696.38
Piramal Enterprises (BSE)
 2602.35 (2.48%)
M.Cap (Rs. in Cr)46996.49
Sun Pharma Inds. (BSE)
 576.30 (3.91%)
M.Cap (Rs. in Cr)138273.07
Glaxosmithkline Phar (BSE)
 2801.00 (0.70%)
M.Cap (Rs. in Cr)23725.32
Shareholding Pattern
PROMOTERS 63.92%
NON-INSTITUTION 21.16%
MUTUAL FUNDS/UTI 8.6%
FI/BANKS/INSURANCE 3.31%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.